Literature DB >> 30368693

Preventing Lethal Prostate Cancer with Diet, Supplements, and Rx: Heart Healthy Continues to Be Prostate Healthy and "First Do No Harm" Part I.

Mark A Moyad1.   

Abstract

PURPOSE OF REVIEW: To discuss the overall and latest observations of the effect of diet, lifestyle, supplements, and some prescription heart healthy medications for prostate cancer prevention. RECENT
FINDINGS: The concept of maximizing heart health to prevent aggressive prostate cancer continues to be solidified with the addition of more prospective observational and randomized controlled trial data. Heart healthy is prostate healthy, but heart unhealthy is prostate unhealthy. The primary goal of reducing the risk of all-cause and cardiovascular disease (CVD) morbidity and mortality also allows for maximizing prostate cancer prevention. The obesity epidemic in children and adults along with recent diverse research has only strengthened the nexus between heart and prostate health. Greater dietary adherence toward a variety of healthy foods is associated with a graded improved probability of CVD and potentially aggressive cancer risk reduction. Preventing prostate cancer via dietary supplements should encourage a "first do no harm", or less is more approach until future evidence can reverse the concerning trend that more supplementation has resulted in either no impact or an increased risk of prostate cancer. Supplements to reduce side effects of some cancer treatments appear to have more encouraging data. Medications that improve heart health including statins, aspirin, and metformin (S.A.M.), and specific beta-blocker medications are primarily generic or low-cost and should continue to garner research interest. A watershed moment in medical education has arrived where the past perception of a diverse number of trees seemingly separated by vast distances, in reality, now appear to exist within the same forest.

Entities:  

Keywords:  Cardiovascular disease; Diet; Prostate cancer prevention; S.A.M.

Mesh:

Substances:

Year:  2018        PMID: 30368693     DOI: 10.1007/s11934-018-0846-4

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   3.092


  95 in total

1.  Alcohol intake increases high-grade prostate cancer risk among men taking dutasteride in the REDUCE trial.

Authors:  Jay H Fowke; Lauren Howard; Gerald L Andriole; Stephen J Freedland
Journal:  Eur Urol       Date:  2014-02-09       Impact factor: 20.096

2.  Urinary lithogenic risk profile in recurrent stone formers with hyperoxaluria: a randomized controlled trial comparing DASH (Dietary Approaches to Stop Hypertension)-style and low-oxalate diets.

Authors:  Nazanin Noori; Elaheh Honarkar; David S Goldfarb; Kamyar Kalantar-Zadeh; Maryam Taheri; Nasser Shakhssalim; Mahmoud Parvin; Abbas Basiri
Journal:  Am J Kidney Dis       Date:  2014-03       Impact factor: 8.860

3.  Estimating how extra calories from alcohol consumption are likely an overlooked contributor to youth obesity.

Authors:  Kate Battista; Scott T Leatherdale
Journal:  Health Promot Chronic Dis Prev Can       Date:  2017-06       Impact factor: 3.240

Review 4.  Meta-analysis of metabolic syndrome and prostate cancer.

Authors:  M Gacci; G I Russo; C De Nunzio; A Sebastianelli; M Salvi; L Vignozzi; A Tubaro; G Morgia; S Serni
Journal:  Prostate Cancer Prostatic Dis       Date:  2017-02-21       Impact factor: 5.554

5.  Coffee Intake, Recurrence, and Mortality in Stage III Colon Cancer: Results From CALGB 89803 (Alliance).

Authors:  Brendan J Guercio; Kaori Sato; Donna Niedzwiecki; Xing Ye; Leonard B Saltz; Robert J Mayer; Rex B Mowat; Renaud Whittom; Alexander Hantel; Al Benson; Daniel Atienza; Michael Messino; Hedy Kindler; Alan Venook; Frank B Hu; Shuji Ogino; Kana Wu; Walter C Willett; Edward L Giovannucci; Jeffrey A Meyerhardt; Charles S Fuchs
Journal:  J Clin Oncol       Date:  2015-08-17       Impact factor: 44.544

6.  Midlife metabolic factors and prostate cancer risk in later life.

Authors:  Barbra A Dickerman; Johanna E Torfadottir; Unnur A Valdimarsdottir; Kathryn M Wilson; Laufey Steingrimsdottir; Thor Aspelund; Julie L Batista; Katja Fall; Edward Giovannucci; Lara G Sigurdardottir; Laufey Tryggvadottir; Vilmundur Gudnason; Sarah C Markt; Lorelei A Mucci
Journal:  Int J Cancer       Date:  2017-11-16       Impact factor: 7.396

7.  Alcoholic beverage consumption contributes to caloric and moisture intakes and body weight status.

Authors:  Francis A Tayie; Garret L Beck
Journal:  Nutrition       Date:  2016-01-29       Impact factor: 4.008

8.  Periprostatic adipose inflammation is associated with high-grade prostate cancer.

Authors:  A Gucalp; N M Iyengar; X K Zhou; D D Giri; D J Falcone; H Wang; S Williams; M D Krasne; I Yaghnam; B Kunzel; P G Morris; L W Jones; M Pollak; V P Laudone; C A Hudis; H I Scher; P T Scardino; J A Eastham; A J Dannenberg
Journal:  Prostate Cancer Prostatic Dis       Date:  2017-06-27       Impact factor: 5.554

9.  Exercise training as a novel primary treatment for localised prostate cancer: a multi-site randomised controlled phase II study.

Authors:  L Bourke; R Stevenson; R Turner; R Hooper; P Sasieni; R Greasley; D Morrissey; M Loosemore; A Fisher; H Payne; S J C Taylor; D J Rosario
Journal:  Sci Rep       Date:  2018-05-30       Impact factor: 4.379

Review 10.  Physical Activity to Improve Erectile Function: A Systematic Review of Intervention Studies.

Authors:  Helle Gerbild; Camilla Marie Larsen; Christian Graugaard; Kristina Areskoug Josefsson
Journal:  Sex Med       Date:  2018-04-13       Impact factor: 2.491

View more
  1 in total

Review 1.  Dietary Factors and Supplements Influencing Prostate Specific-Antigen (PSA) Concentrations in Men with Prostate Cancer and Increased Cancer Risk: An Evidence Analysis Review Based on Randomized Controlled Trials.

Authors:  Maria G Grammatikopoulou; Konstantinos Gkiouras; Stefanos Τ Papageorgiou; Ioannis Myrogiannis; Ioannis Mykoniatis; Theodora Papamitsou; Dimitrios P Bogdanos; Dimitrios G Goulis
Journal:  Nutrients       Date:  2020-09-29       Impact factor: 5.717

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.